Survival In Advanced Diffuse Large B-Cell Lymphoma In Pre- and Post-Rituximab Eras In The United States: A Population Based Study

被引：0
|
作者：
Bista, Amir
Shafii, Bahman
Shah, Binay K.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1747.1747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1747
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Survival in Advanced Diffuse Large B-Cell Lymphoma in Pre- and Post-rituximab Eras in the United States
    Shah, Binay Kumar
    Bista, Amir
    Shafii, Bahman
    ANTICANCER RESEARCH, 2014, 34 (09) : 5117 - 5120
  • [2] LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma in, the pre- and post-rituximab treatment eras
    Natkumam, Yasodha
    Farinha, Pedro
    Hsi, Eric D.
    Hans, Christine P.
    Tibshirani, Robert
    Sehn, Laurie H.
    Connors, Joseph M.
    Zhao, Shuchun
    Pohlman, Brad
    Spinelli, John
    Bast, Martin
    Nagler, Amon
    Levy, Ronald
    Gascoyne, Randy D.
    Lossos, Izidore S.
    BLOOD, 2007, 110 (11) : 24A - 24A
  • [3] Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era
    Jin, Jia
    Gui, Ailing
    Chen, Guangliang
    Liu, Yizhen
    Xia, Zuguang
    Liu, Xiaojian
    Lv, Fangfang
    Cao, Junning
    Hong, Xiaonan
    Yang, Ling
    Gu, Juan J.
    Zhang, Qunling
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (03) : 372 - 380
  • [4] Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era
    Jia Jin
    Ailing Gui
    Guangliang Chen
    Yizhen Liu
    Zuguang Xia
    Xiaojian Liu
    Fangfang Lv
    Junning Cao
    Xiaonan Hong
    Ling Yang
    Juan J. Gu
    Qunling Zhang
    International Journal of Hematology, 2022, 116 : 372 - 380
  • [5] Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab
    Tai, W. M.
    Chung, J.
    Tang, P. L.
    Koo, Y. X.
    Hou, X.
    Tay, K. W.
    Quek, R.
    Tao, M.
    Lim, S. T.
    ANNALS OF HEMATOLOGY, 2011, 90 (07) : 809 - 818
  • [6] Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab
    W. M. Tai
    J. Chung
    P. L. Tang
    Y. X. Koo
    X. Hou
    K. W. Tay
    R. Quek
    M. Tao
    S. T. Lim
    Annals of Hematology, 2011, 90 : 809 - 818
  • [7] THE CLINICAL IMPLICATION OF THE ACTIVATION OF NF-κB SIGNALING PATHWAY IN DIFFUSE LARGE B CELL LYMPHOMA: PRE- AND POST-RITUXIMAB ERA
    Lee, L.
    Liu, J. H.
    Tzeng, C. H.
    Gau, J. P.
    Chen, P. M.
    Chiou, T. J.
    HAEMATOLOGICA, 2015, 100 : 390 - 391
  • [8] Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era
    Tadmor, Tamar
    Bari, Alessia
    Sacchi, Stefano
    Marcheselli, Luigi
    Liardo, Eliana Valentina
    Avivi, Irit
    Benyamini, Noam
    Attias, Dina
    Pozzi, Samantha
    Cox, Maria Christina
    Baldini, Luca
    Brugiatelli, Maura
    Federico, Massimo
    Polliack, Aaron
    HAEMATOLOGICA, 2014, 99 (01) : 125 - 130
  • [9] Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study
    Keegan, Theresa H. M.
    Moy, Lisa M.
    Foran, James M.
    Alizadeh, Ash A.
    Chang, Ellen T.
    Shema, Sarah J.
    Schupp, Clayton W.
    Clarke, Christina A.
    Glaser, Sally L.
    LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 743 - 751
  • [10] Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era
    Dalia, Samir
    Chavez, Julio
    Little, Bryan
    Bello, Celeste
    Fisher, Kate
    Lee, Ji-Hyun
    Chervenick, Paul
    Sokol, Lubomir
    Sotomayor, Eduardo
    Shah, Bijal
    ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1305 - 1312
12345